1
|
Fernández-Ferreira R, Savage-Leyva R, Durán-Guerrero LF, Carranza-Sevilla MDR, Zamorano-Vazquez C, Monroy-Godínez CEF, Hernández-Ramírez GR, Torres-Zazueta JM, Ceron-Ibarra E, Dorantes-Heredia R. Mandibular Metastasis as the First Manifestation of Hepatocellular Carcinoma: A Case Report. Case Rep Oncol 2023; 16:88-95. [PMID: 36820214 PMCID: PMC9938403 DOI: 10.1159/000529182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2022] [Accepted: 01/06/2023] [Indexed: 02/19/2023] Open
Abstract
Metastatic malignancies of the oral cavity are rare lesions, accounting for only 1-4% of all oral malignancies, and can occur in the jaw bones, the oral soft tissues, or even both. Although hepatocellular carcinoma is the most common primary hepatic tumor, no more than 1% of the cases show oral involvement. When metastatic tumor involves the oral cavity, the most frequent site is the posterior angle of the mandible. Histologically, hence, immunohistochemical markers are used for diagnosis. Glypican-3 and HepPar1 are the markers that can be used to confirm the microscopic diagnosis of HCC. Very rarely, hepatocellular carcinoma (HCC) metastasizes to the oral cavity, and such cases have a poor prognosis due to delay in diagnosis. We present a 74-year-old male with a metastasis of HCC in the left mandibular body as the first manifestation. Histologic examination confirmed metastatic hepatocellular carcinoma in the oral mucosa with immunohistochemical (IHC) markers. A review of pertinent literature was performed. Given the rarity of the disease, treatment principles are based mainly on retrospective series and case reports. We report an exceptionally unusual presentation with few cases (<70) reported in the literature, thus representing a diagnostic challenge.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Internal Medicine Department, Tula PEMEX General Hospital, Tula, Mexico
- Internal and Oncology Medicine Department, Tula General Hospital, Tula, Mexico
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Hospital, Mexico City, Mexico
| | | | | | | | | | | | | | - Jose Manuel Torres-Zazueta
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Hospital, Mexico City, Mexico
| | | | | |
Collapse
|
2
|
Fernández-Ferreira R, Romero-López U, Robles-Aviña JA, Rivas-Mendoza UN, González-Camacho C, Valero-Gómez A, Barquet-Mata OA, Reyes-Gabiño A, Tovar-Figueroa KA, Ramírez-Villagrán V. Primary Hepatic Neuroendocrine Carcinoma with Metastasis to the Mesentery: A Case Report. Case Rep Oncol 2023; 16:681-697. [PMID: 37933308 PMCID: PMC10625823 DOI: 10.1159/000533199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 07/10/2023] [Indexed: 11/08/2023] Open
Abstract
Primary hepatic neuroendocrine carcinomas (PHNECs) are extremely rare, with only about 90 cases having been reported in the English-language literature. Among all neuroendocrine neoplasms, primary hepatic neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs) are extremely rare, accounting for 0.3% of NETs and 0.28-0.46% of malignant liver tumors. Additionally, primary hepatic NECs occur infrequently. The clinical diagnosis of primary hepatic NEC remains challenging because of its rarity and the lack of information about its characteristic appearance on images. Consequently, pathological examination through the performance of a preoperative liver tumor biopsy is essential for diagnosis. Due to the lack of availability of substantial high-quality data, there is no standard therapy for primary hepatic NEC. We present the first case of PHNEC metastasized to the mesentery reported in the English-language literature.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Oncology Medicine and Surgical Oncology Department. Central South High Specialty Hospital PEMEX, Mexico City, Mexico
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Ulises Romero-López
- Faculty of Medicine. University of Veracruz. Minatitlan Campus. Heroica Veracruz, Mexico
| | - Jorge Alberto Robles-Aviña
- Oncology Medicine and Surgical Oncology Department. Central South High Specialty Hospital PEMEX, Mexico City, Mexico
| | - Uriel Norberto Rivas-Mendoza
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Casandra González-Camacho
- Imagenology Department, Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Alfredo Valero-Gómez
- Patology Department, Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Omar Armando Barquet-Mata
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Almira Reyes-Gabiño
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Karen Analí Tovar-Figueroa
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| | - Viridiana Ramírez-Villagrán
- Oncology Medicine and Surgical Oncology Department. Tlahuac General Hospital Dr. Matilde Petra Montoya Lafragua, Mexico City, Mexico
| |
Collapse
|
3
|
Fernández-Ferreira R, Soberanis-piña PD, Conde-Flores E, Arroyave-Ramírez AM, Mackinney-Novelo I, Motola-Kuba D, Ruiz-Morales JM, Alvarado-Luna G, Chable-Montero F. Acute Cardiac Tamponade Secondary to Cardiac Vascular-Type Pleomorphic Leiomyosarcoma: Case Report. Case Rep Oncol 2021; 14:1860-1867. [PMID: 35111021 PMCID: PMC8787580 DOI: 10.1159/000520358] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Accepted: 10/13/2021] [Indexed: 11/19/2022] Open
Abstract
Soft tissue sarcomas represent <1% of all neoplasms. Leiomyosarcomas comprise only 5–7% of cases, and only 2% of these are vascular. Vascular leiomyosarcomas are extremely rare and represent only 0.001% of all neoplasms, the venous type being up to 5 times more frequent. Arterial leiomyosarcomas most frequently affect the great vessels, being fatal in most cases. In the reported cases of arterial leiomyosarcomas, the most frequently affected site is the pulmonary artery. We present the clinical case of 2 patients (a 42-year-old woman and a 36-year-old man) with a diagnosis of arterial pleomorphic leiomyosarcoma that conditioned cardiac tamponade as the initial manifestation. As it is an exceptionally rare neoplasm and with few cases reported in the literature, it is important to identify and describe this pathology which, due to the impossibility of offering surgical treatment, represents a therapeutic challenge.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
- *Ricardo Fernández-Ferreira,
| | - Pamela Denisse Soberanis-piña
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Emilio Conde-Flores
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Andrés Mauricio Arroyave-Ramírez
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Ileana Mackinney-Novelo
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Daniel Motola-Kuba
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Jose Manuel Ruiz-Morales
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Gabriela Alvarado-Luna
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Fredy Chable-Montero
- Service of Anatomical Pathology, Medica Sur Clinic & Foundation, Mexico City, Mexico
| |
Collapse
|
4
|
Fernández-Ferreira R, Medina-Ceballos E, Soberanis-piña PD, Conde-Flores E, Arroyave-Ramírez AM, Izquierdo-Tolosa CD, Motola-Kuba D, Ruiz-Morales JM, Dorantes-Heredia R. Neuroendocrine Tumor of the Common Bile Duct: Case Report. Case Rep Oncol 2021; 14:1785-1791. [PMID: 35111010 PMCID: PMC8787518 DOI: 10.1159/000519662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Accepted: 09/14/2021] [Indexed: 11/19/2022] Open
Abstract
Carcinoma of the extrahepatic biliary tract accounts for <2% of all cancers. Neuroendocrine tumor of the extrahepatic bile duct is very rare, and there are <200 cases reported since 1959. The preoperative diagnosis is infrequent (5.12%). The definite diagnosis relies on postoperative pathology which utilized immunohistochemistry study on many biomarkers to diagnose the histological subtypes of neuroendocrine neoplasms, such as chromogranin A, synaptophysin, and neuron-specific enolase. When the primary tumor has no metastases, radical removal of the lesion appears as curative treatment. The treatment of the carcinoid syndrome or other functioning syndrome is the first priority. We report a case of a 12-year-old Mexican woman with neuroendocrine tumor of the extrahepatic bile duct (common bile duct neuroendocrine tumor) seen in our hospital. Resection of the common bile duct, cholecystectomy, end to side Roux-en-y hepaticojejunostomy, and portal lymphadenectomy was performed. A review of the pertinent literature was performed. Given the rarity of the disease, treatment principles are based mainly on retrospective series and case reports. We present the eighth case in adolescence in the literature.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
- *Ricardo Fernández-Ferreira,
| | | | - Pamela Denisse Soberanis-piña
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Emilio Conde-Flores
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Andrés Mauricio Arroyave-Ramírez
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Carlos Daniel Izquierdo-Tolosa
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Daniel Motola-Kuba
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Jose Manuel Ruiz-Morales
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio”, Medica Sur Clinic & Foundation, México City, Mexico
| | - Rita Dorantes-Heredia
- Service of Anatomical Pathology, Medica Sur Clinic & Foundation, México City, Mexico
| |
Collapse
|
5
|
Fernández-Ferreira R, De la Peña-López IR, Zamudio-Coronado KW, Delgado-Soler LA, Torres-Pérez ME, Bourlón-de Los Ríos C, Cortés-González R. Calcitonin-Negative Neuroendocrine Carcinoma of the Thyroid Gland: Case Report and Literature Review. Case Rep Oncol 2021; 14:112-122. [PMID: 33776692 PMCID: PMC7983544 DOI: 10.1159/000510807] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Accepted: 08/07/2020] [Indexed: 11/24/2022] Open
Abstract
Calcitonin-negative neuroendocrine tumor (CNNET) of the thyroid is an extremely rare entity. In some of the previously reported cases within the literature, the terms “atypical medullary thyroid carcinoma,” “calcitonin-free oat cell carcinoma,” and “a distinct clinical entity” were applied to NETs without definitive evidence of calcitonin production. In the English-language literature, not only are there only few reported cases of CNNET, but the criteria for diagnosis in these cases are also controversial. Most of the current published cases were also treated surgically for local disease. We describe a case of NET of the thyroid with calcitonin, chromogranin A and thyroglobulin negativity, synaptophysin and TTF-1 positivity, and a high Ki-67 proliferation index with metastases in the cervical region as well as mediastinal adenopathies. This case was considered an unresectable thyroid carcinoma, and chemotherapy including cisplatin and etoposide was started as neoadjuvant treatment at the department of medical oncology. Total thyroidectomy plus bilateral and central cervical dissection was performed, and the patient underwent 2 cycles of adjuvant radiotherapy. Currently, the patient's <sup>18</sup>F-FDG-PET/CT findings show a complete response 17 months after diagnosis. In conclusion, CNNET of the thyroid is very rare and there is limited evidence regarding treatment in patients with metastases. Chemotherapy including cisplatin and etoposide as well as early aggressive surgical resection appears to positively impact patients' survival.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic & Foundation, Mexico, Mexico
| | - Ildefonso Roberto De la Peña-López
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic & Foundation, Mexico, Mexico
| | - Karla Walkiria Zamudio-Coronado
- Department of Endocrinology, Diabetology and Thyroid, National Institute of Medical Sciences and Nutrition "Salvador Zubiran", Mexico, Mexico
| | | | | | - Christianne Bourlón-de Los Ríos
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic & Foundation, Mexico, Mexico
| | | |
Collapse
|
6
|
Buerba-Vieregge HH, Fernández-Ferreira R, Soberanis-Piña PD, De la Peña-López IR, Navarro-García LM, Macari-Jorge A. Breast Metastasis of Gastric Signet Ring Cell Carcinoma: A Case Report and Literature Review. Case Rep Oncol 2021; 14:165-172. [PMID: 33776699 PMCID: PMC7983628 DOI: 10.1159/000510938] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Accepted: 08/11/2020] [Indexed: 11/19/2022] Open
Abstract
Breast metastasis from gastric signet ring cell carcinoma is extremely rare in clinical practice. The estimated incidence is 0.5-1.3%. There are few cases reported in the literature (approx. less than 60) of breast metastasis from gastric signet ring cell carcinoma, and due to the rare association between gastric cancer and its extension to the breast, it is difficult to establish the diagnosis. Clinical history, histological findings, and immunohistochemical markers are helpful in distinguishing primary breast cancer from breast metastasis of gastric cancer. The treatment for breast metastasis from gastric carcinoma remains controversial. The prognosis of breast metastasis from gastric carcinoma is generally poor. We report a case of breast metastasis of gastric signet ring cell carcinoma in a 38-year-old woman. She started chemotherapy with ramucirumab, paclitaxel, and irinotecan. Three months later, a combined 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography showed a complete response. This is the first reported case of breast metastasis from gastric signet ring cell carcinoma with a complete response.
Collapse
Affiliation(s)
- Héctor Hugo Buerba-Vieregge
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Ricardo Fernández-Ferreira
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Pamela Denisse Soberanis-Piña
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Ildefonso Roberto De la Peña-López
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Lilian Mónica Navarro-García
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Andrés Macari-Jorge
- Service of Anatomical Pathology, Medica Sur Clinic and Foundation, Mexico, Mexico
| |
Collapse
|
7
|
Fernández-Ferreira R, Arroyave-Ramírez A, Motola-Kuba D, Alvarado-Luna G, Mackinney-Novelo I, Segura-Rivera R. Giant Benign Mammary Phyllodes Tumor: Report of a Case and Review of the Literature. Case Rep Oncol 2021; 14:123-133. [PMID: 33776693 PMCID: PMC7983586 DOI: 10.1159/000510741] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Accepted: 08/03/2020] [Indexed: 12/22/2022] Open
Abstract
Phyllodes tumor of the breast is an infrequently encountered fibroepithelial neoplasm, which accounts for 0.3–1% of all tumors. Few case reports have described the occurrence of giant phyllodes tumor. To our knowledge, about 20% of phyllodes tumors would be considered giant benign. Complete surgical excision is the standard of care for giant benign phyllodes tumors; axillary lymph node metastasis is rare, and dissection should be limited to patients with pathologic evidence of tumor in the lymph nodes. We report the case of a 40-year-old Mexican woman with giant mammary tumor who underwent a right total mastectomy. The pathology results showed a benign phyllodes tumor 4,857 g in weight and 40.2 × 36.3 × 15 cm in size. We do not suggest adjuvant radiation therapy for patients with benign phyllodes tumors that are widely excised. A review of the pertinent literature was performed.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Andrés Arroyave-Ramírez
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Daniel Motola-Kuba
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Gabriela Alvarado-Luna
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Ileana Mackinney-Novelo
- Department of Oncology Medicine, Comprehensive Oncology Center "Diana Laura Riojas de Colosio," Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Román Segura-Rivera
- Service of Anatomical Pathology, Medica Sur Clinic and Foundation, Mexico, Mexico
| |
Collapse
|
8
|
Soberanis-Piña PD, Fernández-Ferreira R, Buerba-Vieregge HH, Varela-Santoyo E, Rodriguez-Cid JR, Macari-Jorge A, Dorantes-Heredia R. Myoepithelial Carcinoma Arising in a Plasmacytoid Myoepithelioma of the Parotid Gland Synchronized with Melanoma: A Case Report and Review of the Literature. Case Rep Oncol 2021; 14:173-183. [PMID: 33776700 PMCID: PMC7983609 DOI: 10.1159/000510937] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Accepted: 08/11/2020] [Indexed: 11/19/2022] Open
Abstract
Myoepithelial carcinoma, also known as malignant myoepithelioma, is considered an extremely rare (0.45-1%) malignant salivary gland neoplasm. Approximately 100 cases have been reported in the English-language literature on myoepithelial carcinoma. The majority of the myoepitheliomas described in the literature have been benign, and the malignant counterpart is considered rare (<1%). Such a tumor may appear de novo or rarely develop from a preexisting pleomorphic adenoma (<20%), and in exceedingly rare cases (<0.5%), it has arisen from a benign myoepithelioma (i.e., plasmacytoid myoepithelioma). To our knowledge, no case of myoepithelial carcinoma of the parotid gland arising in a plasmacytoid myoepithelioma synchronized with melanoma has been reported to date. The treatment of myoepithelial carcinoma has been mainly surgical, including wide excision with free margins, with or without nodal dissection. The roles of chemotherapy and radiotherapy have not yet been established. We report a case of myoepithelial carcinoma of the parotid gland arising in a plasmacytoid myoepithelioma synchronized with melanoma in a 40-year-old woman. In our case, a complete response was achieved with surgery followed by adjuvant chemotherapy based on carboplatin and paclitaxel concurrent with radiotherapy.
Collapse
Affiliation(s)
- Pamela Denisse Soberanis-Piña
- Department of Oncology Medicine, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Ricardo Fernández-Ferreira
- Department of Oncology Medicine, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Héctor Hugo Buerba-Vieregge
- Department of Oncology Medicine, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Edgar Varela-Santoyo
- Department of Oncology Medicine, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Jerónimo Rafael Rodriguez-Cid
- Department of Oncology Medicine, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic and Foundation, Mexico, Mexico
| | - Andres Macari-Jorge
- Service of Anatomical Pathology, Medica Sur Clinic and Foundation, Mexico, Mexico
| | | |
Collapse
|
9
|
Fernández-Ferreira R, Alvarado-Luna G, Motola-Kuba D, Mackinney-Novelo I, Cervera-Ceballos EE, Segura-Rivera R. Intergluteal Cleft Eccrine Porocarcinoma with Metastasis to Inguinal Region and Lung: Case Report and Review of the Literature. Case Rep Oncol 2020; 13:1463-1473. [PMID: 33442371 PMCID: PMC7772857 DOI: 10.1159/000510311] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Accepted: 07/19/2020] [Indexed: 11/21/2022] Open
Abstract
Eccrine porocarcinoma (EPC) is an infrequent cutaneous neoplasm, and was described in 1963 by Pinkus and Mehregan. It is a rare type of skin tumor (0.005-0.01% of all skin tumors). Less than 300 cases have been described in the entire world medical literature. To our knowledge, no case of intergluteal cleft EPC has been reported in the literature in English and Spanish to date, so this would be the first reported case of such pathology. Metastatic EPC is less frequent, since only <10% of metastatic type have been reported and the rest as localized disease. The primary treatment of choice is surgical wide local excision of the tumor with histological confirmation of tumor-free margins. Prognosis is difficult to determine because of the rarity of EPC and the variations in natural history. There are no data to support the use of adjuvant chemotherapy or radiotherapy, and there are currently no agreed criteria to define patients at high risk of relapse. We present a 67-year-old man with intergluteal cleft eccrine tumor by biopsy. Metastasis to left inguinal region and lung was reported by contrasted abdominal and chest computed tomography. He started chemotherapy based on etoposide, vincristine, carboplatin. A review of pertinent literature is provided.
Collapse
Affiliation(s)
- Ricardo Fernández-Ferreira
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Gabriela Alvarado-Luna
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Daniel Motola-Kuba
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Ileana Mackinney-Novelo
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Eduardo Emir Cervera-Ceballos
- Oncology Medicine Department, Comprehensive Oncology Center “Diana Laura Riojas de Colosio,” Medica Sur Clinic & Foundation, Mexico City, Mexico
| | - Román Segura-Rivera
- Service of Anatomical Pathology, Medica Sur Clinic & Foundation, Mexico City, Mexico
| |
Collapse
|
10
|
Fernández-Ferreira R, García-Santos RA, Rodríguez-Violante M, López-Martínez C, Becerra-Laparra IK, Torres-Pérez ME. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly. Rev Esp Geriatr Gerontol 2019; 54:251-256. [PMID: 31324404 DOI: 10.1016/j.regg.2019.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 01/28/2019] [Accepted: 04/24/2019] [Indexed: 06/10/2023]
Abstract
INTRODUCTION Progressive supranuclear palsy (PSP) is a syndrome characterized by progressive parkinsonism with early falls due to postural instability, typically vertical gaze supranuclear ophthalmoplegia, pseudobulbar dysfunction, neck dystonia and upper trunk rigidity as well as mild cognitive dysfunction. Progressive supranuclear palsy must be differentiated from Parkinson's disease taking into account several so-called red flags. MATERIALS AND METHODS We report a case series hallmarked by gait abnormalities, falls and bradykinesia in which Parkinson's disease was the initial diagnosis. RESULTS Due to a torpid clinical course, magnetic resonance imaging (MRI) was performed demonstrating midbrain atrophy, highly suggestive of progressive supranuclear palsy. CONCLUSION The neuroradiological exams (magnetic resonance imaging, single photon emission computer tomography, and positron emission tomography) can be useful for diagnosis of PSP. Treatment with levodopa should be considered, especially in patients with a more parkinsonian phenotype.
Collapse
Affiliation(s)
| | - Raúl Anwar García-Santos
- Neurology Department, National Institute of Neurology and Neurosurgery, PC 14269, Mexico City, Mexico
| | - Mayela Rodríguez-Violante
- Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, PC 14269, Mexico City, Mexico
| | - Coral López-Martínez
- Geriatrics Department, Médica Sur Clinic & Foundation, PC 14050, Mexico City, Mexico
| | | | | |
Collapse
|
11
|
Fernández-Ferreira R, Morales-Victorino N, Herrera-Gomar M, Alcántara-Meléndez MA, García-Graullera M, González-Chon O, García-López SM. Stress induced cardiomyopathy due to a Mexican earthquake. Arch Cardiol Mex 2018; 88:219-224. [PMID: 29606490 DOI: 10.1016/j.acmx.2018.02.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Revised: 02/23/2018] [Accepted: 02/23/2018] [Indexed: 11/26/2022] Open
Abstract
Takotsubo Cardiomyopathy mainly occurs in postmenopausal women, with or without cardiovascular disease, and is commonly associated with emotional or physical stress. After nearly 27 years of extensive efforts towards a better understanding of this disorder, current knowledge remains limited. Many people suffer post-traumatic stress, and this situation can be associated to stress cardiomyopathy. The case is presented of a female who suffers stress associated with the earthquake of 19 September 2017 in Mexico City, and arrived in the Emergency Department in cardiogenic shock.
Collapse
Affiliation(s)
| | | | - Magali Herrera-Gomar
- Coronary Care Unit Department, Médica Sur Clinic & Foundation, México City, Mexico
| | | | | | | | | |
Collapse
|